Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Eichhorn

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Postgraduate Medicine|August 12, 2009
Treating patients with severe heart failureEric J Eichhorn
The New England Journal of Medicine|August 5, 2008
Simvastatin with or without ezetimibe in familial hypercholesterolemiaEric J Eichhorn
Progress in Cardiovascular Diseases|May 15, 2002
DigoxinEric J Eichhorn, Mihai Gheorghiade
The New England Journal of Medicine|November 1, 2002
Digoxin--new perspective on an old drugEric J Eichhorn, Mihai Gheorghiade
Circulation|August 15, 2002
Dobutamine challenge for low-gradient aortic stenosisPaul A Grayburn, Eric J Eichhorn
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialEric J Eichhorn, Michael R Bristow
The New England Journal of Medicine|June 2, 2001
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure, Eric J Eichhorn, Michael J Domanski, et al.
Circulation. Heart Failure|October 29, 2009
Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched studyMustafa I Ahmed, Wilbert S Aronow, Michael H Criqui, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
International Journal of Cardiology|June 18, 2010
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failureMihai Gheorghiade, James D Flaherty, Gregg C Fonarow, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Postgraduate Medicine|August 12, 2009
Treating patients with severe heart failureEric J Eichhorn
The New England Journal of Medicine|August 5, 2008
Simvastatin with or without ezetimibe in familial hypercholesterolemiaEric J Eichhorn
Progress in Cardiovascular Diseases|May 15, 2002
DigoxinEric J Eichhorn, Mihai Gheorghiade
The New England Journal of Medicine|November 1, 2002
Digoxin--new perspective on an old drugEric J Eichhorn, Mihai Gheorghiade
Circulation|August 15, 2002
Dobutamine challenge for low-gradient aortic stenosisPaul A Grayburn, Eric J Eichhorn
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialEric J Eichhorn, Michael R Bristow
The New England Journal of Medicine|June 2, 2001
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure, Eric J Eichhorn, Michael J Domanski, et al.
Circulation. Heart Failure|October 29, 2009
Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched studyMustafa I Ahmed, Wilbert S Aronow, Michael H Criqui, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
International Journal of Cardiology|June 18, 2010
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failureMihai Gheorghiade, James D Flaherty, Gregg C Fonarow, et al.
Pageof 2